The aim of this study is to show for the first time that treatment with intravenous fibrinolysis using rt-PA in patients with recent ischemic stroke is accompanied by increases in circulating levels of BDNF, which may reflect an increase in BDNF synthesis in the brain. The analysis of the recovery of functional and cognitive abilities as well as mood at 3 months will allow us to study the impact of BDNF on these parameters. Thus, depending on the results obtained, circulating BDNF could serve as an early marker of these.
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Masking
NONE
Enrollment
50
Centre Hospitalier Universitaire
Dijon, France
Measurement of plasma levels of BDNF
Time frame: Change from baseline at Day1, Day 7 and Month 3
Measurement of serum levels of BDNF
Time frame: Change from baseline at Day1, Day 7 and Month 3
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.